- Home
- NPCE vs LFCR Comparison
NPCE vs LFCR Comparison
Compare NPCE & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- LFCR
- Stock Information
- Founded
- NPCE 1997
- LFCR 1986
- Country
- NPCE United States
- LFCR United States
- Employees
- NPCE N/A
- LFCR N/A
- Industry
- NPCE Medical Specialities
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- NPCE Health Care
- LFCR Health Care
- Exchange
- NPCE Nasdaq
- LFCR Nasdaq
- Market Cap
- NPCE 292.9M
- LFCR 308.8M
- IPO Year
- NPCE 2021
- LFCR N/A
- Fundamental
- Price
- NPCE $9.15
- LFCR $7.61
- Analyst Decision
- NPCE Strong Buy
- LFCR Buy
- Analyst Count
- NPCE 6
- LFCR 4
- Target Price
- NPCE $16.67
- LFCR $8.00
- AVG Volume (30 Days)
- NPCE 205.3K
- LFCR 108.3K
- Earning Date
- NPCE 08-12-2025
- LFCR 08-07-2025
- Dividend Yield
- NPCE N/A
- LFCR N/A
- EPS Growth
- NPCE N/A
- LFCR N/A
- EPS
- NPCE N/A
- LFCR N/A
- Revenue
- NPCE $88,570,000.00
- LFCR $128,867,000.00
- Revenue This Year
- NPCE $22.13
- LFCR $4.78
- Revenue Next Year
- NPCE $6.07
- LFCR $12.02
- P/E Ratio
- NPCE N/A
- LFCR N/A
- Revenue Growth
- NPCE 23.32
- LFCR 0.47
- 52 Week Low
- NPCE $5.45
- LFCR $3.68
- 52 Week High
- NPCE $18.98
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- NPCE 51.74
- LFCR 53.94
- Support Level
- NPCE $8.61
- LFCR $7.33
- Resistance Level
- NPCE $8.99
- LFCR $7.73
- Average True Range (ATR)
- NPCE 0.53
- LFCR 0.30
- MACD
- NPCE 0.11
- LFCR 0.03
- Stochastic Oscillator
- NPCE 75.00
- LFCR 65.33
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.